$ADXN
Addex Therapeutics Ltd American Depositary Shares
XNAS•Health Care•Pharmaceutical Preparations
$5.65
▲+95.50%+$2.76After hours
Addex Therapeutics Ltd American Depositary Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is ADXN up today? It is at $5.65 (+95.50%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ADXN spikes, and full due diligence on ADXN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ADXN 2 times in the last 30 days. Create a free account to track $ADXN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ADXN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on ADXN today, peaking at 2.7x its normal volume. A recent catalyst in the news: “Addex Spin-out Neurosterix Closes $105 Million Series B Financing.” Early read: bullish.
Likely catalystForeign issuer report (6-K), from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Dyer Timothy Mark Officer | Sold (automatic/other) | -16.41M 900.8% of company | sold 97% | 435K | n/a | Sep 2, 26 |
Dyer Timothy Mark Officer | Acquired (grant/award) | +16.41M 900.8% of company | added 100% | 16.85M | n/a | Sep 2, 26 |
Hill Raymond George Director | Sold (automatic/other) | -1.37M 74.9% of company | n/a | n/a | n/a | Sep 2, 26 |
Hill Raymond George Director | Acquired (grant/award) | +1.37M 74.9% of company | n/a | 1.37M | n/a | Sep 2, 26 |
Lawton Vincent Michael Director | Sold (automatic/other) | -2.51M 137.6% of company | sold 100% | 500 | n/a | Sep 2, 26 |
Lawton Vincent Michael Director | Acquired (grant/award) | +2.51M 137.6% of company | added 100% | 2.51M | n/a | Sep 2, 26 |
Manke Isaac Director | Sold (automatic/other) | -220K 12.0% of company | n/a | n/a | n/a | Sep 2, 26 |
Manke Isaac Director | Acquired (grant/award) | +220K 12.0% of company | n/a | 220K | n/a | Sep 2, 26 |
Mills Roger Officer | Sold (automatic/other) | -393K 21.6% of company | sold 50% | 393K | n/a | Sep 2, 26 |
Mills Roger Officer | Acquired (grant/award) | +393K 21.6% of company | added 100% | 786K | n/a | Sep 2, 26 |
Nunn Jason Raleigh Director | Sold (automatic/other) | -220K 12.0% of company | n/a | n/a | n/a | Sep 2, 26 |
Nunn Jason Raleigh Director | Acquired (grant/award) | +220K 12.0% of company | n/a | 220K | n/a | Sep 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
ADXN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on ADXN today, peaking at 2.7x its normal volume. A recent catalyst in the news: “Addex Spin-out Neurosterix Closes $105 Million Series B Financing.” Early read: bullish.
ADXN last traded at $5.65, up 95.50% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Addex Therapeutics Ltd American Depositary Shares (ADXN) is next expected to report earnings on Thursday, December 3, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ADXN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ADXN 2 times in the last 30 days.
ADXN (Addex Therapeutics Ltd American Depositary Shares) trades on XNAS, with a market cap of about $5M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ADXN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ADXN discussion
Sign in to ask a question or join the discussion.